Ki67值越高,是不是说明预后越不好?
(参考文献)
1.Ibrahim T, Farolfi A,Scarpi E,et al.Hormonal receptor,human epidermal growth factor receptor-2,and Ki67 discordance between primary breast cancer and paired metastases:clinical impact[J]. Oncology(Williston Park),2013,84(3):150-157.
2. THANGARAJAH F,ENNINGAI,MALTER W,etal.A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases.[J].AnticancerRes, 2017,37(4):1957-1964.
3.Denkert C,Budczies J, Von MG, et al. Strategies for developing Ki67 as a useful biomarker in breast cancer[J].Breast,2015,24 (Suppl 2):S67-S72.
4. Synestvedt M, Borgen E, Russnes HG, Kumar NT, Schlichting E, Giercksky KE, et al. Combined analysis of vascular invasion, grade,HER2 and Ki67expression identifies early breast cancer patients with questionable benefit of systemic adjuvant
therapy.Acta Oncol.2013;52(1):91-101.
5. Bjer C, Knoop A,Bjee K, Larsen MS, Henriksen KL,Lyng MB, et al. Association of tisue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer. Acta Oncol. 2013;52(1):82-90.
6. Hugh J, Hanson J, Cheang MC,Nielsen TO, Perou CM, Dumontet C,et al. Breast cancer subtypes and response to docetaxel in node-positive breast cancer:use of an immunohistochemical definition in the BCIRG 001 trial. J Clin Oncol.
7. Penault-Llorca F, Andre'F, Sagan C, Lacroix-Triki M, Denoux Y, Verriele V, et al. Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer. J Clin Oncol. 2009;27(17):2809-15.